Grants and Contracts Details
Description
Purpose and Background
HB1 made sweeping changes relative to the prescribing and monitoring of controlled
prescription drugs in an effort to address the prescription drug abuse problem in Kentucky. In
particular, the requirements for mandatory registration and utilization of the Kentucky All
Schedule Prescription Reporting (KASPER) system should assist prescribers in making
appropriate treatment decisions and identifying patients potentially in need of substance abuse
treatment interventions. As with any policy change, unintended consequences that impact
patients and providers may be associated with HB1 implementation. To maximize the
effectiveness of HB1 and minimize unintended consequences, we propose to conduct a
comprehensive assessment of HB1’s impact on patients, prescribers, and citizens in Kentucky
utilizing a mixed-methods approach that includes both qualitative and quantitative components.
Goals and Objectives
The overall goals of the project are to:
1. Evaluate the impact of HB1 on reducing prescription drug abuse and diversion in
Kentucky
2. Identify unintended consequences associated with implementation of HB1 that impact
patients, providers and citizens of the Commonwealth
3. Develop recommendations to improve effectiveness of HB1 and mitigate identified
unintended consequences
Specific Aims
Our quantitative analyses will rely on KASPER administrative data files to examine trends in
KASPER utilization and prescribing, and whether those trends changed systematically after the
introduction of HB1. Additionally, nationally available datasets will be used to assess impact of
HB1 on morbidity and mortality associated with prescription drug overdoses. Our proposed
qualitative component is designed to provide timely insights through a series of semi-structured
interviews with key stakeholders and surveys of KASPER users to determine perceptions of HB1
effectiveness and to identify unintended consequences.
To achieve the above goals, we propose using data available from the KASPER program and
other readily available data sets to address the following specific aims:
1) Assess changes in KASPER utilization since implementation of HB1, including number
of registrants, requests and geographic distribution of registrants
2) Assess changes in controlled substance (CS) prescribing patterns since implementation of
HB1, including number of CS prescribed, demographics of prescribers and drugs
prescribed
3) Assess KASPER user perceptions of the effectiveness of KASPER and the chilling effect
of HB1utilizing surveys and stakeholder interviews
4) Assess changes in patient behavior/characteristics, including doctor shopping, since
implementation of HB1
5) Assess changes in morbidity/mortality indices since implementation of HB1, including
Emergency Department visits and hospital discharges for CS overdose, admission to
substance abuse treatment facilities and deaths due to CS overdose
Status | Finished |
---|---|
Effective start/end date | 7/1/14 → 1/31/15 |
Funding
- KY Cabinet for Health and Family Services: $12,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.